GSK to Buy CureVac's Covid-19, Flu Vaccine Rights for Up to $1.56 Billion [Yahoo! Finance]
Sanofi - American Depositary Shares (SNY)
US:NYSE Investor Relations:
sanofi.com/en/investors
Company Research
Source: Yahoo! Finance
The deal bolsters the U.K. pharmaceutical company's vaccine portfolio at a time when bird-flu concerns are boosting demand. Vaccines accounted for roughly a third of GSK's sales last year. Most Read from The Wall Street Journal Skydance Media's Deal to Buy Shari Redstone's Family Company Is Back On Powell Talks Up Progress, Putting Rate Cuts Back Into View Raids Find Luxury Handbags Being Made by Exploited Workers in Italy Approval of Newest Alzheimer's Drug Will Accelerate New Era of Treatment A Bucket List for Our Retirement? No Thanks GSK's deal with CureVac follows in the footsteps of a vaccine licensing agreement between Sanofi and Novavax in May valued at up to $1.4 billion. Both GSK and Sanofi were among the biggest makers of vaccines before the pandemic, but fell behind rivals and new entrants that launched shots based on messenger RNA, or mRNA, technology as Covid-19 turbocharged demand. The mRNA-based vaccines that were widely used to combat Covid-19 use mes
Show less
Read more
Impact Snapshot
Event Time:
SNY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SNY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SNY alerts
High impacting Sanofi - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
SNY
News
- Dupixent “addresses current gap” in COPD biologics landscape [Yahoo! Finance]Yahoo! Finance
- Three Solid Euronext Paris Dividend Stocks With Yields Up To 7.9% [Yahoo! Finance]Yahoo! Finance
- French State Investment Firm Eyes Stake in Sanofi Consumer Unit [Yahoo! Finance Canada]Yahoo! Finance Canada
- French State Investment Firm Eyes Stake in Sanofi Consumer Unit [BNN Bloomberg (Canada)]BNN Bloomberg
- Kidney Transplant Market to Grow at a 3.3% CAGR from 2024 to 2034, Fueled by Healthcare Spending and Renal Calculi Retrieval Devices Landscape | TMR [Yahoo! Finance]Yahoo! Finance
SNY
Sec Filings
- 7/2/24 - Form 6-K
- 6/28/24 - Form 11-K
- 6/28/24 - Form 11-K
- SNY's page on the SEC website